We are live on ! Find out more
CCM

CAAS Capital Management Portfolio holdings

AUM $934M
1-Year Est. Return 1.45%
This Fund
S&P 500
This Quarter Est. Return
+26.63%
1 Year Est. Return
+1.45%
3 Year Est. Return
+10.99%
5 Year Est. Return
+150.62%
10 Year Est. Return
AUM
$10.5B
AUM Growth
+$6.2B
Cap. Flow
+$4.78B
Cap. Flow %
45.54%
Top 10 Hldgs %
28.07%
Holding
985
New
521
Increased
87
Reduced
60
Closed
171

Sector Composition

Rank Sector Weight
1 Technology 7.01%
2 Healthcare 6.25%
3 Communication Services 2.7%
4 Consumer Discretionary 2.07%
5 Financials 1.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VLTA
526
DELISTED
Volta Inc.
VLTA
$1.6M 0.02%
+150,000
New +$1.57M
SHOP icon
527
PUT
Shopify
SHOP
$160B
$1.58M 0.02%
14,000
TSIAU
528
DELISTED
TS Innovation Acquisitions Corp. Unit
TSIAU
$1.58M 0.02%
+150,000
New +$1.53M
DRI icon
529
Darden Restaurants
DRI
$23.4B
$1.58M 0.02%
+13,250
New +$1.42M
BSN.U
530
DELISTED
Broadstone Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of on
BSN.U
$1.57M 0.02%
150,000
-70,000
-32% -$707K
BYND icon
531
PUT
Beyond Meat
BYND
$327M
$1.56M 0.01%
+12,500
New +$1.89M
MAX icon
532
MediaAlpha
MAX
$758M
$1.56M 0.01%
+40,000
New +$1.55M
ASO icon
533
Academy Sports + Outdoors
ASO
$3.02B
$1.55M 0.01%
+75,000
New +$1.21M
CAP.U
534
DELISTED
Capitol Investment Corp. V Units, each consisting of one share of Class A common stock, and one-thir
CAP.U
$1.54M 0.01%
+150,000
New +$1.53M
IAA
535
DELISTED
IAA, Inc. Common Stock
IAA
$1.53M 0.01%
+23,624
New +$1.41M
SPRO icon
536
Spero Therapeutics
SPRO
$71.2M
$1.52M 0.01%
+78,509
New +$1.22M
LBTYK icon
537
Liberty Global Class C
LBTYK
$3.6B
$1.5M 0.01%
+63,559
New +$1.38M
NEM icon
538
CALL
Newmont
NEM
$103B
$1.5M 0.01%
+25,000
New +$1.54M
EOG icon
539
PUT
EOG Resources
EOG
$76.4B
$1.5M 0.01%
+30,000
New +$1.3M
IVZ icon
540
Invesco
IVZ
$14.1B
$1.49M 0.01%
+85,500
New +$1.32M
NET icon
541
Cloudflare
NET
$107B
$1.49M 0.01%
+19,600
New +$1.29M
TRIL
542
CALL
DELISTED
Trillium Therapeutics Inc.
TRIL
$1.47M 0.01%
+100,000
New +$1.44M
TRIL
543
PUT
DELISTED
Trillium Therapeutics Inc.
TRIL
$1.47M 0.01%
+100,000
New +$1.44M
ADI icon
544
Analog Devices
ADI
$185B
$1.46M 0.01%
9,850
-125,000
-93% -$16.6M
OKTA icon
545
PUT
Okta
OKTA
$25.7B
$1.45M 0.01%
5,700
BP icon
546
CALL
BP
BP
$109B
$1.45M 0.01%
70,500
BBWI icon
547
Bath & Body Works
BBWI
$4.24B
$1.44M 0.01%
+47,728
New +$1.39M
DVN icon
548
Devon Energy
DVN
$50.8B
$1.42M 0.01%
89,927
+73,893
+461% +$916K
MDLZ icon
549
Mondelez International
MDLZ
$79.2B
$1.4M 0.01%
+23,958
New +$1.37M
PSTH
550
PUT
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
$1.39M 0.01%
+50,000
New +$1.21M

Similar funds

CAAS Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, CAAS Capital Management held 985 positions worth $10.5B, up 145% from $4.29B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

CAAS Capital Management deployed $4.78B of net new capital in Q4 2020, opening 521 new positions and adding to 87 existing holdings. Its largest new stake was Sunrun: 1,519,346 shares worth $105M.

By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 7.8% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was First Solar, an estimated $71.8M trimmed.

  • CAAS Capital Management's largest Q4 2020 buy was Sunrun: 1,519,346 shares worth $105M.
  • CAAS Capital Management added most to Royalty Pharma in Q4 2020, an estimated $153M increase.
  • CAAS Capital Management's biggest Q4 2020 reduction was First Solar, cutting an estimated $71.8M.
  • CAAS Capital Management fully exited 10x Genomics in Q4 2020, selling an estimated $62.3M.
  • CAAS Capital Management's ten largest holdings make up 28% of its $10.5B portfolio in Q4 2020.
  • CAAS Capital Management opened 521 new positions and closed 171 in Q4 2020.
  • CAAS Capital Management's portfolio value rose 145% quarter-over-quarter to $10.5B.

Based on CAAS Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.